Dr. Omar Eissa Habo’s Post

Cancer screening needs a refresh. Yes, I said it. And I have my reasons. 🤔 Before I explain, you might be wondering, "But didn't they *just* lower the starting age for breast cancer screening? It was all over the news." You're right and I'm incredibly thankful for the ongoing research that drives these updates. But we need to remain nimble when it comes to #cancerscreening protocols. Here's why: 👂 For those who haven't heard, colon cancer rates are on the rise ⬆ among young adults in their 20s, 30s and 40s. And with delays in diagnosis, we're unfortunately seeing them present with advanced disease that's harder to treat. In recent years, medical societies have lowered ⬇ the starting age for colorectal and breast cancer screening for people who have no symptoms and no family history. However, younger adults are now being diagnosed with these and other cancers, irrespective of family history or traditional risk factors. This underscores the importance of continuing to investigate ALL potential risk factors and taking ⚠ warning signs VERY seriously. 🚨 If you experience symptoms like #blood in your stool or unexplained #weightloss, it's vital not to ignore them. Here's what to do: 1) Understand your family history and discuss it with your relatives (first- and second-degree family members). 2) Tell your healthcare provider about your symptoms and family history to determine if earlier colorectal (CRC) screening is necessary. If you're experiencing significant blood loss or are feeling unwell, don't wait and go to the hospital ASAP. 3) Follow through with recommended screening - doing so will significantly mitigate your risk of developing CRC. In fact, regular screening and removal of polyps reduces your risk of developing CRC by up to 90% with colonoscopy. To learn more about the evolving landscape of CRC screening and warning signs, explore this insightful update from The New York Times: https://lnkd.in/ej5UbEpT Stay safe and stay informed.

Breast and colon cancers are rising among younger people (under 50 years). The global incidence of early-onset cancer increased by 79.1% and early-onset cancer deaths rose by 27.7% from 1990 to 2019, a 2023 study in BMJ Oncology found. Data published last year in the Journal of the American Medical Association showed that from 2010 to 2019 in the United States, breast cancer accounted for the highest number of cases in this younger population, while rates of gastrointestinal cancers were rising the fastest. #oncology #oncologie #oncologist #oncologia #cancer #healthcare #drugdevelopment

Breast and colon cancers are rising among younger people (under 50 years). The global incidence of early-onset cancer increased by 79.1% and early-onset cancer deaths rose by 27.7% from 1990 to 2019, a 2023 study in BMJ Oncology found. Data published last year in the Journal of the American Medical Association showed that from 2010 to 2019 in the United States, breast cancer accounted for the highest number of cases in this younger population, while rates of gastrointestinal cancers were rising the fastest. If you think that this is solely due to changes in diet and activity, think again. This article argues that the rise also includes healthy, active people who eat well. Something is happening to cause these cancers in young people. The article also points out that often a young person’s cancer is found at a much later stage. The USPSTF lowered the breast cancer screening guidelines to 40 years of age. However, younger women tend to have dense breasts. Mammograms, including 3-D tomosynthesis, are less effective in younger, dense breast tissue. Younger women need supplemental screening to find tumors in their dense tissue. This is an issue that not just affects us older generation, but our daughters. #breastcancerscreening #breastcancer

November is Pancreatic Cancer awareness month and we at Unhurry® are committed to spreading awareness about it. Regular screening of people at high risk for pancreatic cancer pays off. Surveillance programs for people at high risk of developing pancreatic cancers can help detect precancerous conditions and cancers early, when they are most treatable, according to a new multicenter study directed by experts at the Johns Hopkins Kimmel Cancer Center. A total of 1,461 individuals at high risk of developing pancreatic cancer were enrolled in the Cancer of Pancreas Screening-5 (CAPS5) study at Johns Hopkins Medicine and seven other medical centers, and underwent annual pancreatic imaging tests. Of these participants, 10 were diagnosed with pancreatic cancer, including one participant who was diagnosed four years after dropping out of recommended surveillance. Seven of the remaining nine patients (77.8%) were diagnosed with stage I disease, and the other two had progressed to higher stage cancer (one had stage IIB, and one had stage III disease). Seven of these patients were alive after a median follow-up of 2.6 years. "A clear majority of patients in the CAPS program who were diagnosed with pancreatic cancer were detected at the first stage of the disease if they maintained their surveillance,” says senior study author Michael Goggins, M.B.B.Ch., M.D., Sol Goldman Professor of Pancreatic Cancer Research and director of the Pancreatic Cancer Early Detection Laboratory. In general, Goggins says, most patients presenting with symptoms already have later-stage pancreatic cancer; very few have their disease detected at stage I. Rachna Chhachhi RachnaRestores®️ Kindness Practice Foundation To read the complete article, please click on the link below. https://lnkd.in/d3akCyNW For more such articles on mental health, well-being and sustainability, don't forget to follow us. #unhurry #mentalhealth #mentalhealthmatters #mentalhealthawareness #mentalhealthsupport #cancer #cancerawareness #pancreaticcancer #pancreaticcancerawareness #cancerpatient #cancerpatients #caregiver #screening #cancerscreening

endometriosis.org: 'Behind the headlines: endometriosis and ovarian cancer' Thank you for posting this, Lone Hummelshoj and peers, with permission from Endometriosis UK. Source: https://lnkd.in/e6NMTyRW You may have seen endometriosis in the news this week regarding research on 'Endometriosis and Ovarian Cancer' published by JAMA, Journal of the American Medical Association [1]. Some news articles have claimed that the research highlights an 'increased risk' of ovarian cancer for those with endometriosis. However, associate professor Karen Schliep from the University of Utah, the senior author of the study, clarifies that given the rarity of ovarian cancer, the excess risk is relatively small. Previous research indicates a small excess risk of ovarian cancer for those with endometriosis: 1.3% in the general population versus 1.8% for those with endometriosis [2]. The new JAMA paper suggests a higher figure, but this may not necessarily be the case. Experts in the UK and USA have raised questions about the study’s methods and the data used. 🔑 Key Takeaway: Ovarian cancers are rare; if you have endometriosis there is a slight increased risk of ovarian cancer and it is good to be aware of symptoms of ovarian cancer. Always consult with your doctor if you have any concerns! Stay informed and prioritize your health! 💪 #Endometriosis #OvarianCancer #HealthAwareness #JAMA - References 1: Barnard M, et al. Endometriosis typology and ovarian cancer risk. JAMA 2024 online ahead of print. https://lnkd.in/e-kHZ9K8. 2: Kvaskoff M, et al. Informing women with endometriosis about ovarian cancer risk. The Lancet 2017;390:2433-34. https://lnkd.in/eQurfWQu.

It’s National Colorectal Cancer Month, something I am very passionate about raising awareness for. Mostly because early detection can save a life! Help me spread awareness! One of the most misunderstood facts about colorectal cancer is that it only affects older adults. While it is more common in older age groups, colorectal cancer can occur in younger individuals as well. This misconception can lead to delayed diagnosis and treatment in younger patients, highlighting the importance of raising awareness about the risk factors and symptoms of colorectal cancer across all age groups. Myth 1: Colorectal cancer exclusively targets the elderly. Fact: While more prevalent among older adults, colorectal cancer can affect individuals of any age. Myth 2: Colorectal cancer is solely hereditary. Fact: While family history can increase the risk, most cases of colorectal cancer are sporadic. Myth 3: Only males develop colorectal cancer. Fact: Both men and women can be diagnosed with colorectal cancer. Myth 4: Prevention of colorectal cancer is impossible. Fact: Healthy lifestyle choices, such as diet and exercise, can lower the risk of colorectal cancer. Myth 5: Colorectal cancer always exhibits noticeable symptoms. Fact: Colorectal cancer can be asymptomatic in its early stages, underscoring the importance of regular screening. Myth 6: Absence of family history means no risk of colorectal cancer. Fact: While family history elevates risk, anyone can develop colorectal cancer. Myth 7: Colorectal cancer is invariably fatal. Fact: With early detection and treatment advances, many individuals survive colorectal cancer. Myth 8: Treatment for colorectal cancer is uniformly aggressive. Fact: Treatment plans vary based on factors like stage and patient preference. Myth 9: Colorectal cancer equates to a terminal diagnosis. Fact: Though serious, many individuals manage colorectal cancer for years. Myth 10: Following a colorectal cancer diagnosis, further screening is unnecessary. Fact: Regular monitoring post-treatment remains crucial to detect any recurrence or new developments. Please, take the time and get screened. It’s better to know now, before it’s too late! #awareness #coloncancer #earlydetection

Protect Your Health During Cancer Treatment: Cancer can be a difficult and overwhelming diagnosis, and if you have cancer or are undergoing cancer treatment, your top priority is to get healthy. After your cancer diagnosis, there are many new things you might need to learn and manage. The Centers for Disease Control and Prevention and the National Blood Clot Alliance want you to protect your health by understanding your risk for dangerous blood clots, because cancer and some cancer treatments can increase your risk for blood clots. About 900,000 people each year are affected by blood clots, and about one in five of these blood clots are associated with cancer. The risk for a blood clot is greatest in the first few months after cancer is diagnosed. Some cancers pose a greater risk for blood clots, including cancers involving the pancreas, stomach, brain, lung, uterus, ovaries and kidneys, as well as blood cancers such as lymphoma and myeloma. The higher your cancer stage, the greater your risk for a blood clot. The type of cancer treatment you receive may increase your risk for blood clots too. Treatments involving hospitalization, surgery, chemotherapy, hormonal therapy, catheters placed in your veins, and some other therapies can increase your blood clot risk. Know the Signs and Symptoms of a Blood Clot Blood clots occur most often in the legs or arms, and symptoms include Swelling. Pain or tenderness not caused by an injury. Skin that may be warm to the touch, red, or discolored.Blood clots in your legs or arms can travel to your lungs, which can be deadly. Symptoms of blood clots in your lungs include: Difficulty breathing. Chest pain that worsens with a deep breath. Coughing up blood. Faster than normal or irregular heartbeat.Contact your cancer doctor immediately if you experience any blood clot symptoms. A Plan to Protect Your Health As you take steps to preserve your health, make blood clot awareness part of your care. Know your risks for blood clots, and discuss these risks with your cancer doctor. Stay alert for any signs or symptoms of blood clots after surgery or treatment in an outpatient clinic. Contact your cancer doctor right away if you experience any of these signs or symptoms. Work with your cancer doctor and make a plan to protect yourself against blood clots that is specific to your personal medical history and treatment. #healthcarenews #DoctorsBusinessNetwork #medicalnews

💉 Could a Cancer Drug Curb the Organ Damage of Severe COVID? 🦠 An experimental cancer drug, eganelisib, might help prevent organ damage caused by severe COVID-19 infections, according to a new study. Eganelisib inhibits the immune system enzyme PI3K gamma, which boosts damaging inflammation in cancerous tumors. Lab studies in mice and human tissue revealed that eganelisib could also suppress organ-damaging inflammation triggered by COVID-19. Severe COVID can damage the heart, gastrointestinal system, kidneys, brain, and nervous system, contributing to Long COVID, a condition with symptoms lasting months or years beyond the initial infection. The findings were published on July 3 in Science Translational Medicine. #COVID19 #CancerResearch #LongCOVID #MedicalBreakthrough https://lnkd.in/dQRAd4uS

𝐇𝐞𝐫𝐞 𝐚𝐫𝐞 𝐬𝐨𝐦𝐞 𝐤𝐞𝐲 𝐠𝐥𝐨𝐛𝐚𝐥 𝐛𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐬𝐭𝐚𝐭𝐢𝐬𝐭𝐢𝐜𝐬 𝐟𝐨𝐫 𝟐𝟎𝟐𝟒: 𝐍𝐞𝐰 𝐂𝐚𝐬𝐞𝐬: Approximately 310,720 women and 2,790 men are expected to be diagnosed with invasive breast cancer. 𝐃𝐮𝐜𝐭𝐚𝐥 𝐂𝐚𝐫𝐜𝐢𝐧𝐨𝐦𝐚 𝐈𝐧 𝐒𝐢𝐭𝐮 (𝐃𝐂𝐈𝐒): Around 56,500 women will receive a diagnosis of DCIS, a non-invasive form of breast cancer. 𝐃𝐞𝐚𝐭𝐡𝐬: Breast cancer will claim the lives of 42,250 women and 530 men. 𝐀𝐠𝐞 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧: About 16% of new cases will occur in women under the age of 50. 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐒𝐮𝐛𝐭𝐲𝐩𝐞: The HR+/HER2- subtype is the most prevalent form of breast cancer. 𝐔𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫: 𝐑𝐢𝐬𝐤𝐬, 𝐒𝐲𝐦𝐩𝐭𝐨𝐦𝐬, 𝐚𝐧𝐝 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐎𝐩𝐭𝐢𝐨𝐧𝐬 Breast cancer occurs when abnormal cells in the breast grow uncontrollably, forming tumors. If left untreated, these tumors can spread to other parts of the body and become life-threatening. The cancer typically starts in the milk ducts or milk-producing lobules. 𝐖𝐡𝐨 𝐢𝐬 𝐚𝐭 𝐑𝐢𝐬𝐤? 𝐆𝐞𝐧𝐝𝐞𝐫: 99% of cases occur in women, though 0.5–1% of cases also affect men. 𝐀𝐠𝐞: Half of breast cancer cases occur in women with no identifiable risk factors besides being female and over 40. 𝐎𝐭𝐡𝐞𝐫 𝐑𝐢𝐬𝐤 𝐅𝐚𝐜𝐭𝐨𝐫𝐬: Age 55+ Family history of breast cancer Genetic predisposition (e.g., BRCA mutations) Smoking Obesity 𝐒𝐢𝐠𝐧𝐬 & 𝐒𝐲𝐦𝐩𝐭𝐨𝐦𝐬 Early stages often present no symptoms, making early detection crucial. As breast cancer progresses, common signs include: A lump or thickening in the breast, often painless Changes in the size, shape, or appearance of the breast Dimpling, redness, or pitting of the skin Unusual or bloody discharge from the nipple 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 Treatment usually starts with surgery, but other therapies may be used depending on the case: Surgery – Sometimes followed by breast reconstruction Chemotherapy Radiation Therapy Hormone Therapy Stay proactive. Regular screenings and self-exams are essential. If you notice unusual changes, seek medical advice early. Let’s spread awareness, support those affected, and work toward a future without breast cancer. #breastcancerawareness #earlydetection #cancertreatment #supportandawareness